[123I]-IBZM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [123I]-IBZM, covering 2008-01-21 to 2008-01-21. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN) [Phase 2]